STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session OCCIM OFS Credit reports quarterly earnings with undisclosed key financial metrics ahead of planned investor call JPMJ J P Morgan reaffirms steady preferred stock payout plans in its latest quarterly earnings report